Can-Fite BioPharma Ltd.
CANF- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001536196
No open-market purchases or sales by Can-Fite BioPharma Ltd. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $149.1K in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Can-Fite BioPharma Ltd. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 15 | 13 | −2 |
| Shares | 486.0K | 381.5K | −104.5K (−21.5%) |
| Value | $626.5K | $472.3K | −$154.1K (−24.6%) |
New holders (3)
Institutions that held Can-Fite BioPharma Ltd. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 11,333 | $14.0K | 0.00% |
| UBS Group AG | 7,181 | $9.00K | 0.00% |
| Captrust Financial Advisors | 1,549 | $2.00K | 0.00% |
Sold out (5)
Institutions that held Can-Fite BioPharma Ltd. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Cetera Advisor Networks LLC | 130,776 | $169.0K |
| Acadian Asset Management LLC | 28,601 | $36.0K |
| Two Sigma Securities, LLC | 17,809 | $23.0K |
| HRT Financial LP | 11,900 | $15.0K |
| Advisor Group Holdings, Inc. | 1,114 | $1.00K |